Replies to post #6555 on Lexington Biosciences Inc. (LXGTF)

[Door2Door]

And the FDA 510K accelerated path to market is why FDA clearance is such a shoe in. LXGTF has already provided early testing info that shows a correlation to ultrasound results re endothelial function. They dont have to reinvent the wheel with the clinicals, only establish that they are as good or better than precursor technology. Which is why I estimate no longer that 6 months from last November.